Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

3.3K
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
3.3K
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

29
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
29
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.9K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

507
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
507
Clinical Trials01:16

Clinical Trials

9.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.8K
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors for partial placental retention after Cesarean delivery: a preliminary report.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2026
Same author

Reply.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2026
Same author

Ultrasound features in early pregnancy for predicting abnormal karyotype in first-trimester miscarriage.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2026
Same author

Endometrial assessment in abnormal uterine bleeding: transvaginal ultrasound alone may not be good enough.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2025
Same author

Interpregnancy interval and risk of recurrence following tubal ectopic pregnancy: retrospective cohort study from UK tertiary center.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2025
Same author

Corrigendum to 'An age-related nomogram for antral follicle counts as a reference guide for reproductive decision making: an observational study of 7573 women' Reproductive BioMedicine Online 49:5 (2025) 104295.

Reproductive biomedicine online·2025

Related Experiment Video

Updated: Oct 19, 2025

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.2K

A protocol for developing, disseminating, and implementing a core outcome set for adenomyosis research.

T Tellum, J Naftalin, M Hirsch

    Facts, Views & Vision in Obgyn
    |September 23, 2021
    PubMed
    Summary

    A core outcome set for adenomyosis will standardize research, improving data synthesis for better treatment guidelines. This aims to provide comparable, patient-centered evidence for heavy and painful periods.

    More Related Videos

    Establishment of an Experimental Mouse Model of Endometrioma to Study its Related Infertility
    08:07

    Establishment of an Experimental Mouse Model of Endometrioma to Study its Related Infertility

    Published on: April 5, 2024

    1.0K
    Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
    11:29

    Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma

    Published on: January 22, 2022

    14.5K

    Related Experiment Videos

    Last Updated: Oct 19, 2025

    Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
    08:26

    Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

    Published on: February 23, 2024

    2.2K
    Establishment of an Experimental Mouse Model of Endometrioma to Study its Related Infertility
    08:07

    Establishment of an Experimental Mouse Model of Endometrioma to Study its Related Infertility

    Published on: April 5, 2024

    1.0K
    Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
    11:29

    Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma

    Published on: January 22, 2022

    14.5K

    Area of Science:

    • Gynecology
    • Reproductive Medicine
    • Clinical Trials

    Background:

    • Adenomyosis is a common gynecological condition linked to heavy/painful periods, infertility, and adverse pregnancy outcomes.
    • Current adenomyosis treatment studies report varied outcomes and measures, hindering data synthesis and clinical practice.
    • This heterogeneity prevents effective meta-analyses and the development of evidence-based guidelines.

    Purpose of the Study:

    • To establish a minimum set of core outcomes for all future studies on uterus-sparing interventions for adenomyosis.
    • To reduce heterogeneity in research and facilitate easier data synthesis.
    • To enable comparable, prioritized, and patient-centered conclusions from meta-analyses and guidelines.

    Main Methods:

    • A systematic literature review identified potential outcomes.
    • An international steering group of stakeholders agreed on a long list of outcomes.
    • A modified Delphi process involving key stakeholders refined the outcome set.
    • Recommendations for high-quality outcome measures will be developed.

    Main Results:

    • A core outcome set for adenomyosis research is being developed.
    • The process involves systematic review, stakeholder consensus, and a Delphi methodology.
    • The refined set will guide future research and improve data comparability.

    Conclusions:

    • Implementing this core outcome set will enhance comparable data availability in adenomyosis trials.
    • This facilitates more patient-centered, evidence-based care for individuals with adenomyosis.
    • The core outcome set will generate clinically significant and patient-centered results for treatment studies.